| 000 | 01825 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513203757.0 | ||
| 264 | 0 | _c20000502 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a0021-9150 | ||
| 024 | 7 |
_a10.1016/s0021-9150(99)00290-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFleischhacker, E | |
| 245 | 0 | 0 |
_aIn human hypercholesterolemia increased reactivity of vascular smooth muscle cells is due to altered subcellular Ca(2+) distribution. _h[electronic resource] |
| 260 |
_bAtherosclerosis _cMar 2000 |
||
| 300 |
_a33-42 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiological Transport, Active _xphysiology |
| 650 | 0 | 4 |
_aCalcium Signaling _xphysiology |
| 650 | 0 | 4 |
_aCalcium-Transporting ATPases _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercholesterolemia _xcomplications |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xcytology |
| 650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
| 650 | 0 | 4 |
_aPhenylephrine _xpharmacology |
| 650 | 0 | 4 |
_aPotassium Chloride _xpharmacology |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aUterus _xblood supply |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 700 | 1 | _aEsenabhalu, V E | |
| 700 | 1 | _aHolzmann, S | |
| 700 | 1 | _aSkrabal, F | |
| 700 | 1 | _aKoidl, B | |
| 700 | 1 | _aKostner, G M | |
| 700 | 1 | _aGraier, W F | |
| 773 | 0 |
_tAtherosclerosis _gvol. 149 _gno. 1 _gp. 33-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0021-9150(99)00290-7 _zAvailable from publisher's website |
| 999 |
_c10658672 _d10658672 |
||